FDG Uptake Predicts Recurrence and Survival in Patients with Unresectable Stage III Non-small Cell Lung Cancer Treated with 74 Gy (RBE) Proton Therapy and Chemotherapy
Year: 2011
Type: article
Authors: Z. Xiang, H. Wen, E. Jeremy, M. O'Reilly, R. Komaki, J.D. Cox, J.Y. Chang
Institution: The University of Texas MD Anderson Cancer Center
Language: English
Subfield: Pulmonary and Respiratory Medicine
Field: Medicine
Domain: Health Sciences
Open Access status: bronze
OpenAlex ID: W2054921828
